 Protein-Serine-Threonine Kinases
"Protein-Serine-Threonine Kinases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors.
| Descriptor ID |
D017346
|
| MeSH Number(s) |
D08.811.913.696.620.682.700
|
| Concept/Terms |
Protein-Serine-Threonine Kinases- Protein-Serine-Threonine Kinases
- Kinases, Protein-Serine-Threonine
- Protein Serine Threonine Kinases
- Protein-Serine-Threonine Kinase
- Kinase, Protein-Serine-Threonine
- Protein Serine Threonine Kinase
- Protein-Threonine Kinase
- Kinase, Protein-Threonine
- Protein Threonine Kinase
- Threonine Kinase
- Kinase, Threonine
- Serine-Threonine Kinase
- Kinase, Serine-Threonine
- Serine Threonine Kinase
- Serine-Threonine Kinases
- Kinases, Serine-Threonine
- Serine Threonine Kinases
- Serine-Threonine Protein Kinases
- Kinases, Serine-Threonine Protein
- Protein Kinases, Serine-Threonine
- Serine Threonine Protein Kinases
- Protein-Serine Kinase
- Kinase, Protein-Serine
- Protein Serine Kinase
- Serine Kinase
- Kinase, Serine
|
Below are MeSH descriptors whose meaning is more general than "Protein-Serine-Threonine Kinases".
Below are MeSH descriptors whose meaning is more specific than "Protein-Serine-Threonine Kinases".
This graph shows the total number of publications written about "Protein-Serine-Threonine Kinases" by people in this website by year, and whether "Protein-Serine-Threonine Kinases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 2 | 5 | | 1994 | 5 | 0 | 5 | | 1995 | 3 | 5 | 8 | | 1996 | 5 | 2 | 7 | | 1997 | 9 | 4 | 13 | | 1998 | 6 | 4 | 10 | | 1999 | 4 | 5 | 9 | | 2000 | 12 | 5 | 17 | | 2001 | 13 | 14 | 27 | | 2002 | 16 | 10 | 26 | | 2003 | 17 | 10 | 27 | | 2004 | 15 | 10 | 25 | | 2005 | 16 | 10 | 26 | | 2006 | 16 | 9 | 25 | | 2007 | 13 | 5 | 18 | | 2008 | 7 | 4 | 11 | | 2009 | 13 | 7 | 20 | | 2010 | 15 | 10 | 25 | | 2011 | 10 | 9 | 19 | | 2012 | 12 | 9 | 21 | | 2013 | 8 | 4 | 12 | | 2014 | 12 | 3 | 15 | | 2015 | 10 | 6 | 16 | | 2016 | 10 | 3 | 13 | | 2017 | 8 | 6 | 14 | | 2018 | 4 | 3 | 7 | | 2019 | 10 | 4 | 14 | | 2020 | 4 | 4 | 8 | | 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Protein-Serine-Threonine Kinases" by people in Profiles.
-
Bennett JA, Young RH, Howitt BE, Croce S, Wanjari P, Zhen C, Da Cruz Paula A, Meserve E, Schoolmeester JK, Westbom-Fremer S, Benzi E, Patil NM, Kooreman L, El-Bahrawy M, Zannoni GF, Krausz T, McCluggage WG, Weigelt B, Ritterhouse LL, Oliva E. A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 Cases. Am J Surg Pathol. 2021 08 01; 45(8):1061-1074.
-
Borzi C, Ganzinelli M, Caiola E, Colombo M, Centonze G, Boeri M, Signorelli D, Caleca L, Rulli E, Busico A, Capone I, Pastorino U, Marabese M, Milione M, Broggini M, Garassino MC, Sozzi G, Moro M. LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments. J Thorac Oncol. 2021 08; 16(8):1298-1311.
-
Schumacher MA, Hsieh JJ, Liu CY, Appel KL, Waddell A, Almohazey D, Katada K, Bernard JK, Bucar EB, Gadeock S, Maselli KM, Washington MK, Grikscheit TC, Warburton D, Rosen MJ, Frey MR. Sprouty2 limits intestinal tuft and goblet cell numbers through GSK3ß-mediated restriction of epithelial IL-33. Nat Commun. 2021 02 05; 12(1):836.
-
Kim J, Lee HM, Cai F, Ko B, Yang C, Lieu EL, Muhammad N, Rhyne S, Li K, Haloul M, Gu W, Faubert B, Kaushik AK, Cai L, Kasiri S, Marriam U, Nham K, Girard L, Wang H, Sun X, Kim J, Minna JD, Unsal-Kacmaz K, DeBerardinis RJ. The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer. Nat Metab. 2020 12; 2(12):1401-1412.
-
Fricke J, Mambetsariev I, Pharaon R, Subbiah S, Rajurkar S, Salgia R. Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report. Medicine (Baltimore). 2020 Nov 13; 99(46):e22323.
-
Abderrahman B, Maximov PY, Curpan RF, Fanning SW, Hanspal JS, Fan P, Foulds CE, Chen Y, Malovannaya A, Jain A, Xiong R, Greene GL, Tonetti DA, Thatcher GRJ, Jordan VC. Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer. Mol Cancer Ther. 2021 01; 20(1):11-25.
-
Takeuchi S, Kagabu M, Shoji T, Nitta Y, Sugiyama T, Sato J, Nakamura Y. Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]. Oncoimmunology. 2020 11 11; 9(1):1838189.
-
Ikeda Y, Sato S, Yabuno A, Shintani D, Ogasawara A, Miwa M, Zewde M, Miyamoto T, Fujiwara K, Nakamura Y, Hasegawa K. High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo. J Gynecol Oncol. 2020 Nov; 31(6):e93.
-
Vernieri C, Ganzinelli M, Rulli E, Farina G, Bettini AC, Bareggi C, Rosso L, Signorelli D, Galli G, Lo Russo G, Proto C, Moro M, Indraccolo S, Busico A, Sozzi G, Torri V, Marabese M, Massimo B, Garassino MC. LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial. ESMO Open. 2020 05; 5(3):e000748.
-
Huang LS, Sudhadevi T, Fu P, Punathil-Kannan PK, Ebenezer DL, Ramchandran R, Putherickal V, Cheresh P, Zhou G, Ha AW, Harijith A, Kamp DW, Natarajan V. Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts. Int J Mol Sci. 2020 Mar 17; 21(6).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|